Market Place
Sourcing Support
Vascarta starts Phase 1 Study of VAS-101 in sickle cell disease
15 Apr 2025 //
PR NEWSWIRE
Vascarta starts Phase I study of VAS101 in osteoarthritis
18 Mar 2025 //
PR NEWSWIRE
VAS101, Novel Curcumin Formulation Reverses Aging Hallmarks
17 Mar 2025 //
PR NEWSWIRE
Vascarta`s patented drug candidate for sickle cell disease
18 Feb 2025 //
PR NEWSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.